Copy to clipboard 
Millstone Medical Outsourcing announces the appointment of Michael Quin as Senior Director of Laboratory Services for Millstone Medical Testing, advancing Millstone’s investment in expanded testing services for global medical device OEMs.
This strategic hire builds on Millstone’s recent testing milestones, including the opening of a new 25,000-square-foot ISO 17025–certified testing facility 12 months ago. Quin’s extensive background in microbiology, sterility assurance, and product development will provide the expertise needed to help clients solve increasingly complex monitoring and contamination challenges.
With more than 25 years of experience in the medical device and pharmaceutical sectors, Quin brings a distinguished career that includes 17 years at Johnson & Johnson’s DePuy, as well as leadership roles at USCI Bard, Anika Therapeutics, Gen Biosurgery, Amgen, and Medtronic. His expertise spans sterility assurance validations, microbiology, contamination control programs, and product development. He holds a Bachelor of Science in Microbiology from the University of Massachusetts Amherst and a Master of Science in Technology Management from Bridgewater State College. Quin has also served as a voting member of AAMI Sterilization Working Groups, contributing to industry policy and regulatory standards.
“Michael’s deep expertise in sterility assurance and laboratory operations makes him the ideal leader to guide Millstone’s next phase of testing growth,” said Karl Neuberger, CEO. “As regulatory requirements intensify and OEMs face mounting pressure for speed and compliance, Michael will ensure our testing services continue to set the industry standard in quality and responsiveness.”
Source: Millstone Medical Outsourcing
